Subscribe Now to unlock all the Features! Learn More
Get Ownership Summary for  
Print Print Add Ownership Summary to Dashboard
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Ownership Summary
Institutional Holders
Total Number of Holders 574
% of Shares Outstanding 53.93%
Total Shares Held 611,032,550
Total Value of Holdings $11,249,109,245.50
Net Activity 37,531,731
 
Top 5 Holders Shares Held Shares Changed
BLACKROCK INC. 42,987,782 (716,619)
FMR LLC 41,978,537 20,730,130
ION ASSET MANAGEMENT LTD. 36,329,620 (2,248,867)
CLAL INSURANCE ENTERPRISES HOLDINGS LTD 32,339,189 3,544,823
MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. 29,118,210 (739,590)

 See All Results
Insider Trades
 Last 3 mos.Last 12 mos.
Number of Insider Trades522
Number of Buys00
Number of Sells522
Net Activity (691,605) (1,412,302)
 
Top 5 TradesShares Traded Date
SHALEV VARDA12,8729/2/2024
DANIELL RICHARD98,9438/12/2024
GRANT ANGUS4,0658/9/2024
GRANT ANGUS12,9138/9/2024
HUGHES ERIC A45,0608/9/2024

 See All Results
5% Ownership (SC 13D & SC 13G Filings)
View Form   Filer  Received  Period 
Download / Print
 
Actions 
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  SC 13G/A   PHOENIX HOLDINGS LTD.  04/09/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  SC 13G   PHOENIX HOLDINGS LTD.  02/01/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  SC 13G/A   CAPITAL RESEARCH GLOBAL INVESTORS  06/09/23   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  SC 13G/A   CAPITAL RESEARCH GLOBAL INVESTORS  02/13/23   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  SC 13G/A   CAPITAL RESEARCH GLOBAL INVESTORS  02/11/22   File this document to a folder.